CIMADAMORE, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 177
EU - Europa 85
AS - Asia 57
AF - Africa 8
Totale 327
Nazione #
US - Stati Uniti d'America 177
GB - Regno Unito 19
SE - Svezia 18
CN - Cina 16
VN - Vietnam 15
DE - Germania 13
SG - Singapore 13
IT - Italia 9
IN - India 8
CH - Svizzera 6
IE - Irlanda 6
RU - Federazione Russa 5
CI - Costa d'Avorio 4
FR - Francia 4
JO - Giordania 4
EE - Estonia 2
FI - Finlandia 2
ZA - Sudafrica 2
BE - Belgio 1
NG - Nigeria 1
SA - Arabia Saudita 1
TG - Togo 1
Totale 327
Città #
Fairfield 25
Chandler 18
Southend 17
Dong Ket 15
Ashburn 13
Seattle 13
Cambridge 12
Woodbridge 12
Singapore 11
Wilmington 11
Princeton 8
Houston 7
Bern 6
Bologna 6
Dublin 6
Abidjan 4
Amman 4
Santa Clara 4
Berlin 3
Jinan 3
Westminster 3
Changsha 2
Helsinki 2
Abeokuta 1
Ann Arbor 1
Beijing 1
Boydton 1
Bremen 1
Brussels 1
Bühl 1
Dearborn 1
Des Moines 1
Falls Church 1
Hangzhou 1
Hebei 1
Hounslow 1
Kuban 1
Lanzhou 1
Las Vegas 1
Lomé 1
London 1
Los Angeles 1
Monmouth Junction 1
Moscow 1
Nanchang 1
Nanjing 1
Olalla 1
Redwood City 1
Riyadh 1
Shenyang 1
Taizhou 1
Tianjin 1
Turin 1
Zhengzhou 1
Totale 236
Nome #
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer 109
The human microbiota and prostate cancer: Friend or foe? 89
Emerging Molecular Technologies in Genitourinary Tumors 86
The molecular characteristics of non‐clear cell renal cell carcinoma: What’s the story morning glory? 34
Towards a new WHO classification of renal cell tumor: What the clinician needs to know-a narrative review 19
New prostate cancer targets for diagnosis, imaging, and therapy: Focus on prostate-specific membrane antigen 10
Totale 347
Categoria #
all - tutte 1.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.213


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202077 0 0 0 2 9 7 10 13 16 15 3 2
2020/202148 12 0 4 0 0 2 0 0 10 2 0 18
2021/202262 2 1 3 4 6 0 2 7 5 1 22 9
2022/2023103 6 8 3 8 8 24 2 6 22 4 1 11
2023/202415 2 4 2 2 3 0 0 0 0 2 0 0
2024/202522 3 14 5 0 0 0 0 0 0 0 0 0
Totale 347